BNP Paribas Financial Markets
KYTH

BNP Paribas Financial Markets’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BNP Paribas Financial Markets’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-68,693
Closed -$5.15M – 3717
2015
Q3 		$5.15M Buy
68,693
+66,469
+2,989% +$4.96M 0.01% 631
2015
Q2 		$167K Buy
2,224
+1,807
+433% +$96.8K ﹤0.01% 1800
2015
Q1 		$20.9K Buy
+417
New +$17.5K ﹤0.01% 2347
2014
Q4 		– Sell
-1,031
Closed -$33.8K – 3985
2014
Q3 		$33.8K Buy
+1,031
New +$36.3K ﹤0.01% 2834
2014
Q2 		– Sell
-69
Closed -$2.25K – 4063
2014
Q1 		$2.25K Sell
69
-126
-65% -$5.64K ﹤0.01% 2620
2013
Q4 		$7.26K Buy
+195
New +$8.09K ﹤0.01% 2856

BNP Paribas Financial Markets's KYTH Position: Q4 2015 in Review

BNP Paribas Financial Markets sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 68,693 shares — an estimated $5.15M sold.

BNP Paribas Financial Markets first reported a position in KYTH in Q4 2013 and held it in 6 quarters. The position peaked at $5.15M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • BNP Paribas Financial Markets reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 68,693 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $5.15M.
  • BNP Paribas Financial Markets first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 6 quarters.
  • BNP Paribas Financial Markets's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $5.15M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2015, filed 10 Feb 2016.